Trevi Therapeutics, Inc. (TRVI) Operating Lease, Liability USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Trevi Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from 2018 to 2024.
  • Trevi Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $1.15 M, a 11.2% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.15 M -$145 K -11.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.19 M +$1.16 M +4289% Dec 31, 2023 10-K 2024-03-20
Q3 2023 $1.22 M +$1.16 M +1903% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.26 M +$1.16 M +1223% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.29 M +$1.17 M +950% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $27 K -$117 K -81.3% Dec 31, 2022 10-K 2023-03-16
Q3 2022 $61 K -$113 K -64.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $95 K -$107 K -53% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $123 K -$107 K -46.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $144 K -$113 K -44% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $174 K -$109 K -38.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $202 K -$106 K -34.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $230 K -$102 K -30.7% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $257 K -$99 K -27.8% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $283 K -$95 K -25.1% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $308 K -$91 K -22.8% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $332 K -$89 K -21.1% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $356 K -$68 K -16% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $378 K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $399 K Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $421 K Mar 31, 2019 10-Q 2019-06-14
Q4 2018 $424 K Jan 1, 2019 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.